Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in AMI with Left Ventricular Failure
NCT00324766Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Jun 2006
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in heart failure (HF), cardiogenic shock, sponsored by Oslo University Hospital. Started Jun 2006; status: completed.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)cardiogenic shock
Beyond the preview
Go deeper on NCT00324766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324766.